Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_assertion type Assertion NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_head.
- NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_assertion description "[Treatment of SLE T cells with PP2Ac-siRNA decreased the protein levels and activity of PP2Ac in a specific manner and increased the levels of phosphorylated cAMP response element-binding protein and its binding to the IL2 and c-fos promoters, as well as increased activator protein 1 activity, causing normalization of IL-2 production.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_provenance.
- NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_assertion evidence source_evidence_literature NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_provenance.
- NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_assertion SIO_000772 16224536 NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_provenance.
- NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_assertion wasDerivedFrom befree-20150227 NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_provenance.
- NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_assertion wasGeneratedBy ECO_0000203 NP638652.RA6QDuv8rzoEMM_NYEl_KP5iHTQXTbAeUM6GWkM2I2_Z8130_provenance.